CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

SEC charges global IT manager in insider trading scheme

By Robert Davis

22:11, 20 September 2021

Mylan Pharmaceuticals – Credit: Shutterstock

The Securities and Exchange Commission charged a former global IT manager on Monday as a part of an $8m (£5.86) insider-trading scheme.  

Dayakar R. Mallu, a former employee of pharmaceutical company Mylan, was charged with avoiding losses by trading on information such as drug test results and then sharing the profits with someone making cash payments in India, according to a press release.

Shares of Viatris, Mylan's owner, were down 1.77% on Monday, falling to $13.33 per share in trading on Nasdaq.

SEC complaint

According to the SEC complaint, Mallu used information from a senior manager at the company to make several strategic decisions regarding “call” and “put” options he took out against Mylan.

In one instance, Mallu bought more than $799,000 in calls prior to Mylan announcing the results of its drugs. After the announcement, shares increased by more than 16%, netting Mallu a profit of more than $691,000.

Two years later when Mylan and Pfizer were working through the terms of a merger, Mallu purchased more than 13,000 call options worth more than $8.4m. He netted more than $2.2m in profits once the merger was announced.

Oil - Crude

71.95 Price
+0.500% 1D Chg, %
Long position overnight fee -0.0179%
Short position overnight fee -0.0040%
Overnight fee time 21:00 (UTC)
Spread 0.03


26,750.60 Price
-0.580% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 60.00


0.53 Price
+1.220% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.00398


1,962.31 Price
-0.070% 1D Chg, %
Long position overnight fee -0.0185%
Short position overnight fee 0.0103%
Overnight fee time 21:00 (UTC)
Spread 0.30

The complaint alleges that Mallu and his associate sought to keep their activities private on encrypted messaging platforms.

However, Scott Thompson, co-acting regional director of the SEC's Philadelphia Regional Office, said that the case “highlights the agency's ability to use sophisticated data analysis to detect suspicious trading patterns and identify the traders behind them.”

About Mylan

Mylan is a global generic pharmaceutical company with more than 7,500 products. Some of its offerings include antiretroviral therapies that people undergoing HIV/AIDs treatments depend on. Its brands are sold in 165 countries around the world, according to a recent financial presentation.

In June 2020, the company’s shareholders approved a merger with Upjohn, the generic arm of Pfizer. This combination helped Mylan enter the European market.

The new company now operates under the name Viatris and trades under the ticker “VTRS”.

Read more: Nasdaq and NYSE sue the SEC over data changes

Rate this article

Capital Com is an execution-only service provider. The material provided on this website is for information purposes only and should not be understood as an investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page then you do so entirely on your own risk.

Still looking for a broker you can trust?

Join the 535.000+ traders worldwide that chose to trade with

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading